BioSpace News Archive

Advanced BioCatalytics (ABC) is pleased to announce the release of BioSS™ SL, a sophorolipid based surfactant used in the cleaning industry. BioSS™ SL is one of several products in ABC’s new line of Fermactants.

Through its collaborative network focused on expanding the application of precision medicine in oncology, Caris will support Huntsman Cancer Institute’s work to understand cancer from its beginnings and use that knowledge to improve cancer treatments

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF ) , a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce a Cooperative Resear

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management’s participation in the following investor and scientific conferences in November: November 16-18 : Stifel

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced that senior management will participate in a fireside chat at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 2:40 p.m. EST. A

SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the presentation of first-time preclinical data for SQZ Antigen Presenting Cells (APCs) in combination with immune-oncology compounds in a poster at the 35th Annual Meeting of The Society for Immun

Results of Investigational Phase 3 KEYNOTE-581/CLEAR Trial (Study 307) to be Presented at Upcoming Medical Meeting

Expanded allogeneic CAR T development collaboration with Servier to include four new programs targeting hematological and solid tumors

Aravive to Receive $12 Million Signing Payment, up to an Additional $207Million in Future Milestone Payments plus Tiered Royalties

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced that the company plans to participate in two upcoming conferences.